Vir Biotechnology Inc (VIR)

7.465 +0.06 (+0.88%) USD  |  NASDAQ  |  Dec 27, 16:00
7.46 0.00 (0.00%) After-Hours: 20:00
More

Vir Biotechnology Research and Development Expense (Quarterly): 195.18M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for VIR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Janux Therapeutics Inc 18.61M
Biomarin Pharmaceutical Inc 184.90M
Arbutus Biopharma Corp 14.27M
GlycoMimetics Inc 1.715M
FibroGen Inc 21.71M